Malaysia IPO Surge Targets 13-Year High as SkyeChip Lists May 20

Malaysia’s initial public offering market has cleared roughly US$1.2 billion in the first four months of 2026, already within touching distance of the US$1.4 billion total for all of last year, according to Bloomberg-compiled data. A May 20 listing of integrated-circuit designer SkyeChip Bhd and a fourth-quarter real estate investment trust (REIT) carve-out from IOI Properties Group Bhd would lift full-year proceeds to roughly US$1.8 billion, the most Bursa Malaysia has cleared in 13 years.

Capital that would normally route through Bangkok or Manila is concentrating in Kuala Lumpur. Bursa is, almost by default, becoming Southeast Asia’s listed proxy for the artificial intelligence (AI) memory cycle, with state-linked funds and provident schemes absorbing institutional tranches at premium subscription multiples.

The Numbers That Frame the 13-Year Mark

The four-month tally already eclipses three of the last four full years on Bursa. All of 2025 closed at US$1.4 billion. 2024 sat below US$1 billion on a softer pipeline. 2022 produced less than US$700 million. The 2013 benchmark, by comparison, was lifted by the Westports Holdings listing and a stack of state-linked privatisations.

Sunway Healthcare Holdings Bhd carried most of the early-2026 proceeds. The hospital group priced its initial offering at RM1.45, raised RM2.86 billion on March 18, and saw its shares jump more than 38% on debut. That single deal accounts for more than half of the year-to-date raise.

The forward calendar is what pushes the math toward the US$1.8 billion mark. SkyeChip will price its 400-million-share base at 88 sen, raising RM352 million, while the IOI REIT is targeting RM1.98 billion in offered units at an indicative 90 sen each. Two further names, Creador-backed pharmacy chain Big Caring Group and convenience operator KK Mart Retail Bhd, have filed draft prospectuses.

Why Capital Is Crowding Into Kuala Lumpur

Two regional comparisons explain the rotation. Thailand’s political turbulence, household debt, and tighter fundraising rules have weighed on the SET; growth there is forecast at 1.9% for 2026 by AMRO’s Thailand macro surveillance work. The Philippine economy slipped to the slowest in major ASEAN, with Q1 2026 GDP growth coming in below Vietnam, Indonesia, Lao PDR and Malaysia.

Malaysia recorded 5.3% Q1 growth. The ringgit has been steady. The political backdrop has remained intact since the unity government formed in late 2022. For a regional fund manager building an ASEAN book this year, that is the lowest-friction venue available, and Deloitte’s Southeast Asia IPO rebound assessment shows the regional volume increasingly concentrating in Malaysia, Indonesia and Vietnam.

Specific Malaysian policy moves are also showing up in earnings. The National Energy Transition Roadmap and the National Semiconductor Strategy have moved from announcement into delivery, and listed companies in the affected sectors are reporting margin uplift to their books for the first time.

What that adds up to, on the ground:

• A liquid local pension and provident-fund bid that anchors institutional tranches at price
• A retail base that has been waiting since the post-COVID listing freeze and is currently subscribing the chip tranche at 95 times
• Lower competition from Thailand and the Philippines for the Southeast Asia AI-exposure trade

Inside SkyeChip’s Cornerstone Book

The cornerstone book counted 22 investors who took 155 million shares, equivalent to 58.6% of the institutional offering and 8.6% of the enlarged share capital. Named participants include Khazanah Nasional Bhd (through Pantai Feringgi Ventures), the Employees Provident Fund Board, Lembaga Tabung Haji, Lembaga Tabung Angkatan Tentera, Great Eastern Life Assurance, and JPMorgan Asset Management’s Singapore arm. Those 155 million shares carry a six-month moratorium on disposal under Bursa’s listing rules, which keeps the majority of the institutional tranche off-screen until mid-November. The retail tranche tracked the same way. The public-offer book was oversubscribed by 95.03 times, the heaviest retail demand on a Bursa Main Market issue since PetroChemical (M) Bhd’s 2010 listing, which cleared 73 times. Oppstar Bhd, the 2023 ACE Market chip-design comparable, cleared 77.

I expect the market to continue to be quite vibrant to be able to raise sizable amounts in the near term.

That came from Raymond Chooi, regional head of equity capital markets at Maybank Investment Bank, in remarks reported by Bloomberg this month. Maybank is also a joint advisor on the IOI Properties REIT, which makes the comment as much positioning as forecast. The RM352 million raise is heavily weighted to research: RM211.5 million, or 60%, lands in R&D, with the rest split across facilities expansion, licensing, tools and working capital. The company designs silicon intellectual property for high-performance computing and counts an HBM3E (high-bandwidth memory generation 3 extended, the specification used in current NVIDIA AI equity stacks and the wider accelerator order book) interface among its commercial product lines.

The Q4 Swing Factor From IOI Properties

IOI Properties Group Bhd announced in April it would carve out RM7.58 billion of retail and hospitality property, anchored by IOI City Mall and W Kuala Lumpur, into a real estate investment trust. The structure offers up to 2.2 billion units to the public at an indicative 90 sen each, raising as much as RM1.98 billion, per the IOI Properties REIT carve-out announcement. IOI Properties retains 60% post-listing. Maybank Investment Bank and AmInvestment Bank are joint advisors; DBS Bank acts as global coordinator.

Net gearing at the parent is forecast to drop to roughly 69%, from 89.6% at end-2025, on a combination of REIT proceeds and recent land disposals. That makes the carve-out as much a balance-sheet event for IOI Properties as a capital-raising one for unit holders.

For Bursa’s full-year tally, the arithmetic is direct. Take the year-to-date US$1.2 billion. Add the chip-design IPO’s roughly US$83 million. Layer the REIT’s roughly US$465 million at the top end of the indicative range, and the year clears around US$1.75 billion without any further pipeline.

Big Caring Group, the pharmacy chain targeting a valuation of up to RM20 billion, and the KK Mart Retail convenience-store carve-out, would each push the headline past US$1.8 billion if either prices before December.

The pacing matters. A late-November or early-December REIT window puts the deal into year-end tax-loss flows and the closing of institutional books. The earlier the REIT moves, the more cushion the year-end number carries against any AI-cycle wobble at the chip name.

What the Oppstar Parallel Tells Listing-Day Bidders

Comparable hunting takes you to March 2023, when Oppstar Bhd opened its ACE Market debut at 63 sen and closed first session at RM2.43, a 286% premium. That remains the largest listing-day move from a Malaysian chip-design name, in a Penang cluster that MIDA’s chip-startup tracking work has been mapping since 2022. Oppstar’s retail tranche cleared 77 times oversubscribed at the time, just short of the current chip listing’s 95 times.

Three years on, Oppstar trades roughly 50% below that listing-day close. The pattern from the 2023 cohort, including Cape EMS Bhd, suggests the day-one pop is real but is also when the institutional cornerstone tranche begins its earliest secondary-market exit window.

Two reads follow for SkyeChip bidders. The first is that listing-day demand on a Malaysian chip-design name has historically been hot enough to break the indicative range; bookbuilds above 70 times oversubscription have all paid on day one in this cohort. The pattern parallels the pre-IPO demand pulse Cathie Wood has flagged on SpaceX in the US private-listing calendar. The second is that price discovery comes later, once the cornerstone moratorium starts unwinding and the first quarterly earnings update is on the tape.

The cornerstone moratorium clears around November 20, six months after the listing. The first quarterly earnings update will land before then. Those two events, not the opening bell, are when the listed chip-design name becomes a real price-discovery story for buyers who arrive at 88 sen.

Memory Cycle, Rate Path and FX Will Decide the Final Tally

Three conditions can move the post-2013 claim from in-reach to missed.

1. The AI memory cycle turns. The chip-design issuer’s R&D allocation rides on HBM3E and successor specifications staying in NVIDIA, AMD and hyperscaler order books. A pullback in Samsung or SK hynix HBM3E capacity utilisation, or a price reset in DRAM (dynamic random-access memory), would compress forward earnings before the November cornerstone moratorium clears.
2. The REIT prices into a tougher window. Bursa’s REIT segment has been priced off a Bank Negara Malaysia overnight policy rate of 3.00% for most of the year. A surprise hike, or a sharper US Federal Reserve path, would pressure unit pricing on the IOI Properties carve-out and risk the deal being trimmed or pushed into 2027, the way Airtel Africa’s listing has slipped its earlier timetable.
3. FX translation breaks the dollar headline. The 2026 league table is denominated in dollars in the Bloomberg dataset everyone is citing. A weaker ringgit shrinks the dollar headline even when the ringgit raise lands on plan; a stronger ringgit does the reverse.

The cornerstone moratorium expires in mid-November. The IOI REIT is targeted to price before December. The first quarterly update from the chip issuer lands in late August. The order in which those three events arrive will determine whether Bursa closes 2026 against its post-2013 high, or with a story about how the AI memory cycle outran the listing pipeline.

If memory pricing softens before November, the listed chip name reprices first, the REIT books a discount, and the year ends a few hundred million dollars short of the May headline. If the cornerstone unwind lands into a still-hot HBM order book and the REIT prices into a friendly retail market, the post-2013 line clears with room to spare, and the back-half pipeline of Big Caring and KK Mart starts being priced into a more confident 2027 window than anyone is currently underwriting.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Securities markets carry risk; valuations, allocations and listing-day outcomes can move sharply in either direction. Consult a licensed financial professional before acting on any of the information above. Figures are accurate as of publication on May 18, 2026.